Not Registered? Register Now.

1. My Profile >2. Additional Information

By submitting below you certify that you have read and agree to our privacy policy.

FR3L

ETFS 3x Daily Long CAC 40

ETFS 3x Daily Long CAC 40 (FR3L) is designed to enable investors to gain a three times daily leveraged 'long' exposure to CAC 40® NR (CAC 40) by tracking the CAC 40® X3 Leverage NR (the "Index"). A three times daily leveraged long exposure means that the product is designed to reflect three times the daily percentage change in the CAC 40. For example, if the CAC 40 was to rise in value by 5% on a particular day, the product would increase in value by 15% on that day (before fees, expenses and adjustments). FR3L is an exchange traded product ("ETP"). It is not a UCITS. Securities in this ETP are structured as debt securities and not as shares (equity) and can be created and redeemed on demand by authorised participants and are traded on exchange just like shares in a company. The ETP is backed by swaps. The payment obligations of the swap counterparty to the Issuer are protected by collateral held in a segregated account at The Bank of New York Mellon.
Fund Overview
Base Currency EUR
Currency hedged No – this product is not protected against adverse currency movements
Daily Change -0.50%
ISIN JE00B89ZNT11
Leverage Factor 3x
Physical delivery No
Price (NAV) €12.99
Underlying Exposure French Equities
Net Asset Value 16 Nov 2018
NAV €12.99
Daily Change -€0.07
Daily Return -0.50%
Total AUM of fund €590,953.42
Shares Outstanding 45,488
Structure
Domicile Jersey
Replication method Synthetic - fully funded collateralised swap
Legal form Debt security
Legal structure ETC
Legal Tax
ISA Eligible
Sharia compliant No
Securities regulator Financial Conduct Authority (FCA UK)
SIPP Eligible
UCITS Eligible Eligible
Key Service Providers
Trustee The Law Debenture Trust Corporation p.l.c.
Issuer ETFS Equity Securities Limited
Registrar Computershare Investor Services (Jersey) Ltd
Collateral manager The Bank of New York Mellon
Counterparty Societe Generale
Fees
MER 0.70%
Entry / Exit fees None when traded on Exchange
Passported Countries
Austria Austria
Denmark Denmark
Finland
France
Germany
Ireland
Italy
Netherlands
Norway
Spain Spain
Sweden
United Kingdom

Listings & Codes

Listings & Codes

Performance

i
The above chart presents information about the difference between the daily market price for shares of the Fund and the Fund's net asset value. The market price is determined using the midpoint between the highest bid and the lowest offer on the listing exchange, as of the time that the Fund's NAV is calculated (usually 4:00 p.m. eastern time for most Funds). The vertical axis of the chart shows the premium or discount expressed as a percentage of mid-point.

Performance is total return based on the growth of a hypothetical 10K based unit value net of fees using daily NAV. Historical performance is not an indication of future performance and any investments may go down in value.
Index Details

CAC 40® X3 Leverage NR

 

The Index is a total return index which is designed to provide a three times daily leveraged long exposure to CAC 40® NR (CAC 40). Each trading day returns, before fees, expenses and adjustments, will be positive when the CAC 40 rises relative to the previous day's close, and negative when the CAC 40 falls relative to the previous day's close. In the event of a large fall in the value of CAC 40 during the course of a trading day it is possible that an intra-day reset may be triggered with respect to the Index in order to restrict the loss in value of the Index as more particularly described in the prospectus.

Leveraged ETPs are only intended for investors who understand the risks involved in investing in an ETC with leveraged exposure and who intend to invest on a short-term basis. Any investment in a leveraged ETP should be monitored on a daily basis to ensure consistency with your investment strategy. Please refer to the section entitled "Risk Factors" in the relevant prospectus for further details of these and other risks associated with an investment in leveraged ETPs. You should consult an independent investment adviser prior to making an investment in a leveraged ETP in order to determine its suitability to your circumstances.

 

Index Details

Index Details
Index Name CAC 40® X3 Leverage NR
Index Provider Euronext
Index Constituent Count 40
Index Type Net Total Return
Currency EUR
Bloomberg Ticker CAC3L Index
Reuters Index Ticker .CAC3L
Index Website https://indices.nyx.com
Security 15 Nov 2018
1. TOTAL 9.23%
2. LVMH 9.05%
3. L'OREAL 7.42%
4. SANOFI 6.58%
5. AIRBUS 5.06%
6. BNP PARIBAS ACT.A 3.84%
7. AXA 3.58%
8. HERMES INTL 3.55%
9. KERING 3.31%
10. SAFRAN 3.17%
11. VINCI 3.14%
12. AIR LIQUIDE 3.05%
13. DANONE 2.86%
14. SCHNEIDER ELECTRIC 2.47%
15. ORANGE 2.45%
16. PERNOD RICARD 2.38%
17. CREDIT AGRICOLE 2.16%
18. DASSAULT SYSTEMES 1.93%
19. ENGIE 1.91%
20. VIVENDI 1.86%

Collateral Details

Currency (weighting) 15 Nov 2018
1. EUR 82.24%
2. CHF 17.76%
Country (weighting) 15 Nov 2018
1. FRANCE 55.83%
2. ITALY 25.54%
3. SWITZERLAND 17.76%
4. GERMANY 0.87%
Constituents Top 20 15 Nov 2018
1. BNP Paribas SA 7.60%
2. Intesa Sanpaolo SpA 6.10%
3. Pernod Ricard SA 5.59%
4. SCOR SE 4.84%
5. Atlantia SpA 4.62%
6. Terna Rete Elettrica Nazionale SpA 3.99%
7. LVMH Moet Hennessy Louis Vuitton SE 3.90%
8. L'Oreal SA 3.90%
9. Swisscom AG 3.84%
10. Peugeot SA 3.82%
11. Dassault Systemes SE 3.81%
12. Electricite de France SA 3.76%
13. UBS Group AG 3.72%
14. Hermes International 3.62%
15. Credit Suisse Group AG 3.61%
16. Eni SpA 3.36%
17. Enel SpA 3.32%
18. Arkema SA 2.95%
19. FinecoBank Banca Fineco SpA 2.69%
20. ABB Ltd 2.23%

Factsheets and Reports


Product


Prospectus


KID


Other Documents


Regulatory


Collateral


Prospectus Summary Translation

DISCLAIMERS

 

This financial promotion has been issued and approved for the purpose of section 21 of the Financial Services and Markets Act 2000 by WisdomTree UK Limited (“WTUK”) which is authorised and regulated by the United Kingdom Financial Conduct Authority. Any performance data displayed on this site is denominated in the trading currency (unless stated otherwise) and does not reflect movements in the exchange rate between the trading currency and any other currency. Adverse exchange rates can significantly affect the value of your investment if your investment is not denominated in the trading currency. Exchange rate risk should always be considered when analysing performance denominated in another currency. Any benchmark performance information does not illustrate the effect of fees and expenses. This information is historical information. Past performance is not a reliable indicator of future results. Certain information may have been prepared by persons other than WTUK or its affiliates. WTUK (and its directors, employees, officers, agents and affiliates) is not responsible in any way for the content of any such information. Investments may go up or down in value and you may lose some or all of the amount invested. Past performance is not a reliable indicator of future performance. You should consult an independent investment adviser prior to making any investment in order to determine its suitability to your circumstances. Any decision to invest should be based on the information contained in the prospectus (and any supplements thereto) of the relevant product which includes information on certain risks associated with an investment. None of the index providers referred to herein nor their licensors make any warranty or representation whatsoever either as to the results obtained from use of the relevant indices and/or the figures at which such indices stand at any particular day or otherwise. None of the index providers shall be liable to any person for any errors or significant delays in the relevant indices nor shall be under any obligation to advise any person of any error or significant delay therein. Securities or shares referred to on this page are not obligations of or guaranteed by any of the counterparties referred to herein or any of their affiliates. Each of the counterparties disclaims all and any liability whether arising in tort, contract or otherwise which it might have in respect of this document or its contents otherwise arising in connection herewith.